Core Viewpoint - SiriusXM Holdings faces significant challenges in the competitive audio streaming market despite its monopoly on satellite radio in the U.S. and a loyal customer base [1][2][15] Company Overview - SiriusXM is the only satellite radio provider in the U.S. with approximately 33 million subscribers, offering ad-free news, sports, podcasts, and other audio content [4] - The platform features popular personalities like Howard Stern, Andy Cohen, and Jeff Lewis, which helps maintain its subscriber base [5] Financial Performance - The company has not seen double-digit revenue growth in several years, and its subscriber base decreased by about 40,000 in Q3 2025 [6] - SiriusXM's stock has declined by two-thirds over the past five years, and it underwent a 1-for-10 reverse stock split in September 2024 [7][8] - The current market capitalization is $7 billion, with a stock price of $21.68 and a P/E ratio of 8 [10][13] Dividend and Cash Flow - SiriusXM has maintained a dividend payout since 2016, currently at $1.08 per share annually, resulting in a dividend yield of 5% [11] - The company generated over $1.2 billion in free cash flow over the trailing 12 months, with a dividend cost of $366 million, allowing for continued payouts and share repurchases [12] Future Outlook - Over the next five years, SiriusXM is expected to struggle to outperform the market but may appeal to income investors due to its dividend yield and share repurchase strategy [14] - The company faces ongoing challenges from audio streaming alternatives, a declining subscriber count, and lacks clear catalysts for growth [15]

Core Points - Jiuzi Holdings Inc. has approved a reverse stock split at a ratio of 1-for-40 to meet Nasdaq's minimum bid requirement of $1.00 per share [1][2] - The reverse stock split will be effective on December 10, 2025, and trading will commence on a split-adjusted basis on December 11, 2025 [3] - The number of outstanding shares will decrease from approximately 50,231,389 to about 1,255,785 following the reverse stock split [4] Company Impact - The reverse stock split will uniformly affect all holders of ordinary shares without changing their percentage ownership in the company [5] - Shareholders will not need to take any action, as the changes will be reflected in their accounts automatically [5]

Core Viewpoint - XBP Global Holdings, Inc. has announced a 1-for-10 reverse stock split, effective December 12, 2025, to enhance its stock price and market perception [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split was authorized by stockholders at the Annual Meeting on July 25, 2025, where every ten shares will be combined into one share [2]. - No fractional shares will be issued; stockholders entitled to fractional shares will receive cash based on the closing price on the effective date [2]. - Post-split, XBP Global will have approximately 11.75 million shares of common stock outstanding, with adjustments made to outstanding warrants, stock options, and other derivative securities [3]. Group 2: Company Overview - XBP Global is a multinational technology and services company specializing in intelligent workflows, with operations in 20 countries and around 11,000 employees [5]. - The company partners with over 2,500 clients, including many Fortune 100 companies, to facilitate hyper-automation and digital transformation [5][6].

Core Viewpoint - MetaVia Inc. announced a 1-for-11 reverse stock split of its common stock, effective December 4, 2025, to comply with Nasdaq's continued listing requirements [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will convert every 11 shares of common stock into one share, maintaining the par value of $0.001 per share [2][3]. - Following the split, the number of outstanding shares will decrease from approximately 25.4 million to about 2.3 million, while the authorized shares will remain at 100 million [4]. Group 2: Impact on Stock Options and Warrants - The reverse stock split will proportionately reduce the number of shares issuable upon conversion of restricted stock units, stock options, and warrants, while increasing their conversion and exercise prices accordingly [3]. Group 3: Company Overview - MetaVia Inc. is focused on transforming cardiometabolic diseases, currently developing DA-1726 for obesity treatment and vanoglipel (DA-1241) for Metabolic Dysfunction-Associated Steatohepatitis (MASH) [6]. - DA-1726 is a dual agonist that has shown best-in-class potential for weight loss and glucose control in Phase 1 trials [6]. - Vanoglipel has demonstrated positive effects on liver inflammation and glucose metabolism in pre-clinical studies and Phase 2a clinical trials [6].

Core Insights - Tilray Brands (TLRY) stockholders approved a 1-for-10 reverse stock split, which will take effect on December 1, 2025, leading to a significant drop in share value, with losses nearing 40% for the year [1][4][6] Company Actions - The reverse stock split will reduce the number of outstanding shares from approximately 1.16 billion to 116 million, with every 10 shares being combined into one [2] - The company anticipates that this change could make its stock more appealing to institutional investors and save up to $1 million annually in costs associated with its annual meeting [4] Market Reaction - Following the announcement, Tilray's shares fell over 20% in a single trading session, reflecting investor concerns about the company's future performance [1][6] - Historically, reverse stock splits are perceived negatively by investors, often indicating a lack of confidence in the stock's upward potential [4]

Core Viewpoint - Tilray Brands, Inc. will implement a one-for-ten reverse stock split of its common stock, effective December 1, 2025, to align its share structure with similar companies and enhance attractiveness to institutional investors [1][2][3][8]. Summary by Sections Reverse Stock Split Details - The reverse stock split will reduce the number of outstanding shares from approximately 1.16 billion to 116 million, with every ten shares converting into one [3]. - Fractional shares will not be issued; instead, stockholders will receive cash for any fractional shares [3]. - The split-adjusted shares will begin trading under the same symbol (TLRY) on December 2, 2025 [2]. Objectives of the Reverse Stock Split - Aligning the number of shares outstanding with companies of similar size and scope [8]. - Making Tilray more attractive to institutional shareholders [8]. - Reducing expenditures associated with the Annual Meeting of Stockholders, resulting in potential annual cost savings of up to $1 million [8]. Company Overview - Tilray Brands is a global lifestyle and consumer packaged goods company with operations in multiple regions, including Canada, the U.S., Europe, Australia, and Latin America [5]. - The company aims to be a leading premium lifestyle brand with a diverse portfolio of over 40 brands across more than 20 countries, focusing on cannabis, hemp-based foods, and craft beverages [5].

Core Points - Lion Group Holding Ltd. (NASDAQ: LGHL) executed a reverse stock split at a ratio of 13 for 1 on November 26, 2025, aimed at increasing the stock price by reducing the number of shares outstanding [1] - The ratio of American Depositary Shares (ADSs) to Class A ordinary shares will change from 2,500 to 32,500, effectively acting as a one-for-thirteen reverse ADS split for ADS holders [2] - LGHL's current stock price is $0.43, reflecting a 4.71% increase, with a trading range today between $0.39 and $0.44, and significant volatility over the past year with a high of $16.4 and a low of $0.30 [3] - The company's market capitalization is approximately $45.6 million, with a trading volume of 161,207 shares, indicating the company's size and stock liquidity [4]

As filed with the U.S. Securities and Exchange Commission on November 25, 2025. Registration No. 333-290902 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PMGC HOLDINGS INC. (Exact name of registrant as specified in its charter) Nevada 5912 33-2382547 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R. ...

As filed with the U.S. Securities and Exchange Commission on November 25, 2025. Registration No. 333-290428 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PMGC HOLDINGS INC. (Exact name of registrant as specified in its charter) Nevada 5912 33-2382547 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R. ...

Core Viewpoint - INVO Fertility, Inc. will implement a 1-for-8 reverse stock split effective November 28, 2025, to enhance its stock price and maintain compliance with Nasdaq listing requirements [1][2]. Company Overview - INVO Fertility is a healthcare services company focused on the fertility market, particularly in expanding assisted reproductive technology (ART) care [3]. - The company's strategy includes building, acquiring, and operating fertility clinics, specifically "INVO Centers" that offer the intravaginal culture (IVC) procedure using the proprietary INVOcell medical device [3]. - INVO Fertility currently operates two INVO Centers and one IVF clinic in the United States and distributes the INVOcell technology to third-party fertility clinics [3]. - The IVC procedure is designed to provide a more natural, intimate, and cost-effective alternative to traditional IVF, with comparable results at a lower cost [3].